|
|||||
|
|
Extramedullary disease relapse and progression after blinatumomab therapy for treatment of acute lymphoblastic leukemia |
|
| Authors: | Ibrahim Aldoss MD Salman Otoukesh MD Jianying Zhang PhD Sally Mokhtari PhD Dat Ngo PharmD Mona Mojtahedzadeh MD Monzr M Al Malki MD Amandeep Salhotra MD Haris Ali MD Ahmed Aribi MD Karamjeet S Sandhu MD Shukaib Arslan MD Paul Koller MD Brian Ball MD Forrest Stewart MD Peter Curtin MD Andrew Artz MD Ryotaro Nakamura MD Guido Marcucci MD Stephen J Forman MD Anthony S Stein MD Vinod Pullarkat MD |
| Institution: | 1. Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California;2. Department of Computational and Quantitative Medicine, City of Hope National Medical Center, Duarte, California;3. Department of Clinical and Translational Project Development, City of Hope National Medical Center, Duarte, California;4. Department of Pharmacy, City of Hope National Medical Center, Duarte, California;5. Department of Clinical Supportive Care, City of Hope National Medical Center, Duarte, California |
| Abstract: | |
| Keywords: | acute lymphoblastic leukemia (ALL) blinatumomab extramedullary refractory relapse |